7月8日,据Fierce Biotech报道,全球眼科器械龙头爱尔康已签署协议,将收购眼科光疗创新企业LumiThera公司及其用于治疗早中期干性年龄相关性黄斑变性(AMD)的PBM光生物调节治疗设备——VALEDA。图片来源:Fierce Biotech全球首款且唯一,创新技术博得巨头青睐本次爱尔康收购的LumiThera公司颇具潜力。据了解,LumiThera公司专注于治疗眼部损伤和疾病,其...
Source Link7月8日,据Fierce Biotech报道,全球眼科器械龙头爱尔康已签署协议,将收购眼科光疗创新企业LumiThera公司及其用于治疗早中期干性年龄相关性黄斑变性(AMD)的PBM光生物调节治疗设备——VALEDA。图片来源:Fierce Biotech全球首款且唯一,创新技术博得巨头青睐本次爱尔康收购的LumiThera公司颇具潜力。据了解,LumiThera公司专注于治疗眼部损伤和疾病,其...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.